Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Detailed Description of Staph Infection

21.07.2004


The rapid and deadly method that destroys the body’s defenses against the common bacterial cause of disease, Staphylococcus aureus (staph), has been identified by researchers at the University of California, San Diego (UCSD) School of Medicine.



Published online the week of July 19, 2004 in the journal Proceedings of the National Academy of Sciences (PNAS), the study describes the detailed cellular mechanisms by which Staphylococcus aureus protein A, or SpA, spreads within minutes throughout the body to preferentially target specific immune cells, causing those cells to commit suicide, making them unable to stop the staph infection.

Found on the skin and in the noses of healthy people, the staph bacteria is a common cause of minor illnesses such as food poisoning, as well as a major cause of life-threatening blood-borne infections like sepsis, and also serious infections of the bone called osteomyelitis and heart-valve infections called endocarditis. Unfortunately, staph has developed tremendous antibiotic resistance, nd there are no vaccines available.


According to the study’s senior author, Gregg J. Silverman, M.D., UCSD professor of medicine and director of the UCSD Rheumatic Disease Core Center, “we discovered that SpA is especially excellent at killing the B lymphocytes now believed to be central to the immune system defense from bacterial infections like staph. It is also important as these same B cells can be a source in other people of crippling diseases like rheumatoid arthritis and lupus, so this could lead to new therapies to suppress responses that are the cause of autoimmune diseases.”

In the UCSD study, Silverman and post-doctoral fellow Carl S. Goodyear, Ph.D., introduced the SpA toxin to mice. They found that within minutes, the SpA had selectively targeted specific B lymphocytes (only those with certain antigen receptors), but not all B cells. Other cells in the body were not damaged. Within several hours, the targeted B cells were almost completely eliminated in the splenic marginal zone (MZ), which is an important area of the immune system.

Unexpectedly, the team found that a single dose of the SpA toxin was able to suppress the B cells for several months, much longer than they anticipated.

The UCSD study was funded by grants from the National Institutes of Health, the Alliance for Lupus Research, the Cancer Research Institute and the National Blood Foundation.

| newswise
Further information:
http://www.ucsd.edu
http://medicine.ucsd.edu/rdcc/silverman.shtml

More articles from Health and Medicine:

nachricht Organ-on-a-chip mimics heart's biomechanical properties
23.02.2017 | Vanderbilt University

nachricht Researchers identify cause of hereditary skeletal muscle disorder
22.02.2017 | Klinikum der Universität München

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Safe glide at total engine failure with ELA-inside

On January 15, 2009, Chesley B. Sullenberger was celebrated world-wide: after the two engines had failed due to bird strike, he and his flight crew succeeded after a glide flight with an Airbus A320 in ditching on the Hudson River. All 155 people on board were saved.

On January 15, 2009, Chesley B. Sullenberger was celebrated world-wide: after the two engines had failed due to bird strike, he and his flight crew succeeded...

Im Focus: Breakthrough with a chain of gold atoms

In the field of nanoscience, an international team of physicists with participants from Konstanz has achieved a breakthrough in understanding heat transport

In the field of nanoscience, an international team of physicists with participants from Konstanz has achieved a breakthrough in understanding heat transport

Im Focus: DNA repair: a new letter in the cell alphabet

Results reveal how discoveries may be hidden in scientific “blind spots”

Cells need to repair damaged DNA in our genes to prevent the development of cancer and other diseases. Our cells therefore activate and send “repair-proteins”...

Im Focus: Dresdner scientists print tomorrow’s world

The Fraunhofer IWS Dresden and Technische Universität Dresden inaugurated their jointly operated Center for Additive Manufacturing Dresden (AMCD) with a festive ceremony on February 7, 2017. Scientists from various disciplines perform research on materials, additive manufacturing processes and innovative technologies, which build up components in a layer by layer process. This technology opens up new horizons for component design and combinations of functions. For example during fabrication, electrical conductors and sensors are already able to be additively manufactured into components. They provide information about stress conditions of a product during operation.

The 3D-printing technology, or additive manufacturing as it is often called, has long made the step out of scientific research laboratories into industrial...

Im Focus: Mimicking nature's cellular architectures via 3-D printing

Research offers new level of control over the structure of 3-D printed materials

Nature does amazing things with limited design materials. Grass, for example, can support its own weight, resist strong wind loads, and recover after being...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Booth and panel discussion – The Lindau Nobel Laureate Meetings at the AAAS 2017 Annual Meeting

13.02.2017 | Event News

Complex Loading versus Hidden Reserves

10.02.2017 | Event News

International Conference on Crystal Growth in Freiburg

09.02.2017 | Event News

 
Latest News

New pop-up strategy inspired by cuts, not folds

27.02.2017 | Materials Sciences

Sandia uses confined nanoparticles to improve hydrogen storage materials performance

27.02.2017 | Interdisciplinary Research

Decoding the genome's cryptic language

27.02.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>